In the United States, Asian Americans and Hispanic Americans consistently report the lowest overall cancer incidence rates among major racial and ethnic groups, but those broad labels hide striking variation depending on the cancer type, the specific subpopulation, and even how many generations a family has lived in the country. Globally, the picture shifts further: regions of West Africa and South-Central Asia record rates several times lower than those in Australia, New Zealand, or Northern Europe. The honest answer is that no single ethnicity “has the lowest cancer rate” in any universal sense, because the ranking reshuffles dramatically once you look beyond all-cancers-combined statistics.
How Cancer Rates Vary Around the World
The most comprehensive snapshot comes from GLOBOCAN, the cancer surveillance project run by the International Agency for Research on Cancer. Its 2022 estimates show that age-adjusted incidence rates among men ranged from over 500 per 100,000 in Australia and New Zealand down to under 100 per 100,000 in Western Africa. Among women, the spread was similarly wide, from over 400 per 100,000 in Australia and New Zealand to close to 100 per 100,000 in South-Central Asia.1PubMed. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries That is a four- to fivefold gap, and it exists even after adjusting for the age structure of each population.
Part of the explanation is economic. Countries that have undergone industrial and dietary transitions tend to report incidence rates two to three times higher than countries still in transition.2PubMed. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries But economics alone does not explain the pattern. Wealthier countries also do more screening, catch more early-stage tumors, and register cases more thoroughly. Lower-income countries with limited cancer registries almost certainly undercount their true burden. So while the rates in West Africa and South-Central Asia are genuinely lower than in high-income countries, the exact size of the gap is uncertain.
The U.S. Landscape by Race and Ethnicity
Within the United States, federal cancer surveillance groups people into broad racial and ethnic categories: non-Hispanic white, non-Hispanic Black, Hispanic/Latino, Asian American and Pacific Islander (sometimes broken out further), and American Indian/Alaska Native. In the most recent data, Asian Americans and Hispanic Americans have the lowest age-adjusted overall cancer incidence rates among these groups, while non-Hispanic Black individuals tend to have the highest mortality rates and non-Hispanic white individuals often have the highest incidence of specific cancers like melanoma and certain lung cancers.
But these rankings shift the moment you drill into individual cancer types. For liver cancer, the pattern reverses: Asian American and Pacific Islander populations historically had the highest incidence, followed by Hispanic populations, then non-Hispanic Black and non-Hispanic white individuals.3PubMed Central. Temporal changes in sex and race/ethnicity incidence rate ratios for hepatocellular carcinoma in the United States, 1992–2022 Stomach cancer shows a similar inversion, with Korean Americans experiencing roughly sevenfold higher incidence of certain gastric cancers than South Asian Americans.4Cancer Epidemiology, Biomarkers & Prevention. One Size Does Not Fit All: Marked Heterogeneity in Incidence of and Survival from Gastric Cancer among Asian American Subgroups For breast cancer, Native Hawaiian women have higher postmenopausal incidence than white women, in part because of differences in circulating sex hormone levels.5American Association for Cancer Research. Racial/Ethnic Differences in Postmenopausal Endogenous Hormones: The Multiethnic Cohort Study In short, the group with “the lowest rate” depends entirely on which cancer you are asking about.
The Hispanic Paradox
One of the more puzzling findings in cancer epidemiology is that Hispanic Americans have lower mortality from nearly every major cancer than non-Hispanic white Americans, despite being more likely to live in poverty, have limited health insurance, and face barriers to care. This pattern is sometimes called the Hispanic paradox, and it has been replicated across decades of data.6Population, Space and Place. Spatial Variation in the Hispanic Paradox: Mortality Rates in New and Established Hispanic US Destinations
Lung cancer is where the gap is most dramatic. Hispanic lung cancer mortality runs at roughly 35 to 40 percent of the rates seen in non-Hispanic whites and African Americans.7PubMed Central. Socioeconomic deprivation as a determinant of cancer mortality and the Hispanic paradox in Texas, USA Historically lower smoking rates among Hispanic women and later adoption of smoking among Hispanic men are part of the explanation. But the advantage extends beyond smoking-related cancers, suggesting that diet, social cohesion, and the “healthy migrant” effect (immigrants tend to be healthier than the population they leave) all play a role. The paradox weakens with successive generations born in the United States, which points toward environmental and lifestyle factors rather than genetics as the main driver.
Why “Asian American” Is Too Broad a Category
Grouping all Asian Americans together is one of the biggest sources of confusion in cancer statistics. The category lumps together Chinese, Japanese, Korean, Filipino, Vietnamese, South Asian, Pacific Islander, and many other populations with very different diets, migration histories, and disease profiles. When researchers break the data apart, the heterogeneity is stark.
For most cancer sites, Asian Americans as a whole have lower cancer mortality than non-Hispanic whites. But stomach and liver cancer mortality is dramatically elevated among Chinese, Korean, and Vietnamese Americans, for whom these two cancers combined account for 15 to 25 percent of all cancer deaths, compared to less than 5 percent in non-Hispanic whites.8PubMed Central. The burden of cancer in Asian Americans: a report of national mortality trends by Asian ethnicity Those elevated rates are linked to higher prevalence of hepatitis B and C virus infection and Helicobacter pylori infection in the countries of origin, along with dietary patterns that include more salt-preserved foods.9British Journal of Cancer. Cancer health disparities in racial/ethnic minorities in the United States
Meanwhile, South Asian Americans have some of the lowest rates of gastric cancer recorded in any U.S. subgroup. Treating “Asian Americans” as a single bloc masks both the high-risk and the low-risk populations within it, and it can lead to screening resources being misdirected.
Diet, Lifestyle, and the Acculturation Effect
Traditional diets appear to explain a meaningful share of the cancer-rate differences between ethnic groups. Among Asian populations, dietary patterns that emphasize vegetables, legumes, fish, and fermented soy products are associated with lower colorectal cancer risk. A meta-analysis of cohort studies found that healthy dietary patterns were linked to roughly a 15 percent reduction in colon cancer risk.10PubMed Central. Dietary factors and colorectal cancer risk in Asian populations: a systematic review and meta-analysis of cohort studies Mediterranean-style and traditional Asian dietary patterns have separately been flagged as protective.11PubMed Central. Diet is Linked to Colorectal Cancer Risk among Asian Adults: A Scoping Review
Soy consumption gets special attention because Asians eating a traditional soy-rich diet have lower incidences of breast and prostate cancer than Western populations, and those rates climb when Asian immigrants adopt a Western diet.12PubMed. Mechanisms of cancer chemoprevention by soy isoflavone genistein This is one of the clearest pieces of evidence that lifestyle, not genetics alone, is shaping the ethnic cancer gap.
The acculturation effect is visible across multiple immigrant groups. Among Middle Eastern immigrants to California, first-generation arrivals had lower cancer risk than non-Hispanic whites, but second and later generations saw their risk approach that of the broader U.S. population.13PubMed Central. Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013 The speed of the shift depends on the cancer site. Colon and stomach cancer rates can change within one or two generations, while breast and prostate cancer may take three or more generations to converge with the host-country rates.14PubMed Central. Epigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibility The different timescales suggest that some cancers respond quickly to changes in diet and behavior, while others involve slower biological processes, possibly including epigenetic changes passed across generations.
Data Quality and the Undercounting Problem
Before taking any racial cancer statistic at face value, it is worth understanding how messy the underlying data can be. Cancer registries in the United States typically assign race and ethnicity from hospital medical records, which rely on how staff perceive or record a patient’s background rather than how the patient self-identifies. A recent study found that cancer registry data often did not match an individual’s self-identified race or ethnicity, with American Indian and Alaska Native individuals being especially likely to have their race misclassified.15PubMed Central. Accuracy of patient race and ethnicity data in a central cancer registry
One earlier study in North Carolina estimated about 18 percent misclassification of American Indians who were not members of federally recognized tribes, which directly leads to undercounting their cancer burden.16PubMed. Misclassification of American Indian race in state cancer data among non-federally recognized Indians in North Carolina That matters because funding for prevention, screening, and treatment programs is tied to recorded disease rates. If an ethnic group’s cancer cases are being assigned to the wrong category, that group’s true cancer rate is underestimated and its resources are shortchanged.
Screening intensity adds another layer of distortion. Populations with higher mammography and colonoscopy rates will detect more cancers, especially early-stage tumors that might otherwise go unrecorded. A study of American Samoan women found that only about a third of those over 40 had ever had a mammogram, and roughly a quarter had an age-appropriate mammogram in the prior year.17Elsevier / ScienceDirect (Preventive Medicine). Breast Cancer Screening among American Samoan Women Groups with less screening will appear to have lower incidence on paper, even if their underlying disease burden is comparable to groups that screen more aggressively. Whenever you see that one ethnic group has a much lower cancer rate, you should always ask whether the difference reflects biology or access.
What Genetics Can and Cannot Explain
Genetic variation between populations does play a role in cancer susceptibility. Certain enzymes involved in metabolizing tobacco carcinogens, alcohol, and hormones vary in frequency across racial groups, and some of these variants have been linked to cancer risk. For example, polymorphisms in genes involved in androgen metabolism may contribute to differences in prostate cancer risk between populations of European and African descent.18Genetics in Medicine. Review of studies on metabolic genes and cancer in populations of African descent But most genome-wide studies of cancer risk have been conducted predominantly in people of European ancestry, which limits what we can confidently say about genetic susceptibility in other groups.19PubMed Central. Exploring genetic susceptibility to cancer in diverse populations
This Eurocentric research bias creates a practical problem. Polygenic risk scores, which combine the effects of many common genetic variants to estimate a person’s cancer risk, work several times better in people of European descent than in people of other ancestries.20PubMed Central. Clinical use of current polygenic risk scores may exacerbate health disparities When tested in a racially diverse biobank, adding polygenic risk scores to prediction models increased accuracy by 1 to 4 percent in people of European ancestry but by less than 1 percent in people of African ancestry for most cancers.21PubMed Central. Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank The scores are not useless across ancestries — the top 10 percent of a breast cancer risk score distribution showed enrichment of actual cases across European, African, East Asian, and South Asian groups — but the precision drops, meaning clinical decisions based on them could be unreliable for non-European populations.22PLOS Genetics. On cross-ancestry cancer polygenic risk scores
The upshot is that genetics contributes to ethnic differences in cancer risk, but the tools we have to measure that contribution are biased toward one group. Attributing an entire ethnic cancer gap to genes is unsupported; so is dismissing genetics entirely.
The Gut Microbiome Connection
An emerging area of research looks at whether the communities of microbes living in the gut might partly explain racial differences in cancer, particularly colorectal cancer. Pilot data show that even after controlling for diet, socioeconomic status, and treatment, microbiome composition differs significantly by race and ethnicity. In one study, the bacterium Fusobacterium nucleatum, which has been linked to the development and progression of colorectal cancer, was found at significantly higher levels in Black/African American participants compared to other groups.23PubMed Central. Associations between the Gut Microbiota, Race, and Ethnicity of Patients with Colorectal Cancer: A Pilot and Feasibility Study A separate profiling study confirmed that the relative abundance of that same bacterium was higher in African Americans than in Caucasian Americans.24PubMed Central. Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans
This research is still in early stages, and the studies are small. No one has shown that microbiome differences cause cancer disparities rather than merely correlating with them. But the findings are worth watching, because the microbiome is modifiable through diet and potentially through targeted interventions. If specific microbial signatures turn out to be causally linked to higher cancer risk in certain populations, that would open a new avenue for reducing disparities that does not depend on closing gaps in income or insurance coverage.
When Lower Incidence Does Not Mean Better Outcomes
A low cancer incidence rate is not the same as a low cancer death rate. Black women in the United States have an overall cancer incidence rate that is about 8 percent lower than that of white women, but their overall cancer death rate is 12 percent higher.25PubMed. American Cancer Society’s report on the status of cancer disparities in the United States, 2021 That gap reflects later-stage diagnosis, less access to high-quality treatment, and potentially more aggressive tumor biology in some cancer types. It is a stark reminder that asking “which ethnicity has the lowest cancer rate” captures only part of the story.
Similarly, some populations with genuinely low incidence rates for certain cancers have poor survival once diagnosed, because the healthcare infrastructure in their communities is less equipped to detect and treat those cancers early. American Indian and Alaska Native populations, for instance, face both undercounting of cases and reduced access to timely treatment in many parts of the country, making it difficult to draw confident conclusions from their reported rates alone.
Should Screening Guidelines Be Tailored by Ethnicity?
Given all the variation described above, there is growing policy interest in whether cancer screening guidelines should factor in race or ethnicity. The idea has intuitive appeal: if a group has substantially higher risk for a specific cancer, starting screening earlier or screening more frequently in that group could catch more cases at treatable stages. A recent analysis in the Annals of Internal Medicine noted that race- and ethnicity-based screening programs focused on high-risk groups could offer a practical alternative to screening the general population, where the overall yield may be too low to justify the costs and harms.26PubMed. The Ethics of Cancer Screening Based on Race and Ethnicity
The counterargument is that race is a crude proxy for the actual risk factors driving the disparity. If the reason Korean Americans have high stomach cancer rates is largely Helicobacter pylori infection, the more precise intervention is to screen for that infection, not to screen everyone who checks “Korean” on a form. If Black men have higher prostate cancer incidence partly because of genetic variants in androgen metabolism pathways, a genetic test is more informative than a checkbox. And for groups whose reported rates are artificially low because of data misclassification or low screening uptake, tailoring guidelines to the recorded rates could deepen the very disparities the policy is meant to address. The ethical terrain here is genuinely complicated, and the field has not reached consensus.
Sex Differences That Cut Across Ethnicity
It is worth noting that for most cancer types, the male-female gap in incidence is larger than the gap between ethnic groups. An analysis of U.S. data from 2000 to 2019 found that among 49 cancer sites examined, 44 showed higher incidence in men, a pattern that held across racial and ethnic groups.27PubMed Central. Sex Differences in Cancer Incidence Rates by Race and Ethnicity: Results from the Surveillance, Epidemiology, and End Results (SEER) Registry (2000–2019) Only a few cancers, such as gallbladder and anal cancer, showed inconsistent sex ratios across ethnic groups. Biological sex, through hormonal exposures, immune function, and behavioral differences, remains one of the strongest predictors of overall cancer risk, often overshadowing racial and ethnic categories.